Back in 2017, the healthcare expenditure in the GCC was estimated to reach $104.6 billion in 2022. Now, all the pre-COVID-19 assumptions are vaporizing in thin air, and everyone is back to the drawing board.
How will the healthcare industry cope with a shift that was uncalled for? How will it adapt to the changes in patients’ behavioural patterns, and address their fears and arising phobias? What role will a healthcare brand play in a post-COVID-19 new normal, and how will it manage to assert its role a leading innovator in an era where health became the prime concern?
To find out the answers, download our latest white paper “Branding Healthcare” now, by filling the form.